COCRYSTAL PHARMA, INC. Litigation Settlement, Expense
COCRYSTAL PHARMA, INC. (COCP) reported Litigation Settlement, Expense of $1.00 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2020-11-13
- COCRYSTAL PHARMA, INC. litigation settlement, expense for the quarter ending 2020-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. litigation settlement, expense for the quarter ending 2020-06-30 was $0.00.
- COCRYSTAL PHARMA, INC. litigation settlement, expense for the quarter ending 2020-03-31 was $1.00M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month |
|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $1.00M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |